Company Overview

RTI Health Solutions (RTI-HS) is a prominent business unit of RTI International, providing comprehensive research and consulting services to biopharmaceutical companies globally. Recognized for employing objective and rigorous scientific methodologies, RTI-HS offers customized solutions across various domains, including health economics, patient-centered outcomes, market access, pharmacoepidemiology, and risk management. As a non-profit and independent organization, it specifies itself as a leader in life science consultancy, driven by core values such as integrity, excellence, innovation, respect, equity, and objectivity.

RTI-HS's team consists of over 370 professionals, many of whom are equipped with master's and Ph.D.-level qualifications. This skilled workforce enables the company to apply industry-specific insights with scientific precision to their projects, upholding high ethical and fiscal standards.

Services Offered

RTI-HS delivers a variety of specialized services designed to support evidence-based decision-making and strategic navigation for their clients:

Health Economics and Patient-Centered Outcomes Assessment: To enable informed decision-making processes.

Market Access and Outcomes Strategy: Assists in navigating complex regulatory environments to ensure successful market entry.

Real-World Evidence Generation and Benefit-Risk Assessments: Critical for underpinning product development and commercialization strategies.

Extensive capabilities in Biostatistics, HTA and Reimbursement Submissions, and Medical Writing.

Expertise spanning multiple therapeutic areas including Oncology, Neurology, Cardiovascular, Infectious Diseases, among others.

Leadership Team

RTI-HS's leadership is composed of experienced professionals committed to strategic direction and excellence:

Christopher R. Simmons, MS, CPA, serves as Senior Vice President, leveraging extensive experience in clinical research management, financial, and operational management.

Senior Scientific Leadership

Rohit Borker: Senior Vice President, specializes in Value, Access, and Health Economics.

Kati Copley-Merriman: Vice President, focuses on market access, outcomes research, and reimbursement strategies.

Stephanie Earnshaw: Senior Fellow known for her contributions to health economics.

Sheri Fehnel: Vice President, recognized for her expertise in Patient-Centered Outcomes Assessment.

Senior Operations Leadership

Susan Barker: Senior Director, drives digital marketing strategy.

Tim Farris: Senior Director, leads technology initiatives.

Jacco Keja: Senior Vice President, heads strategic consulting and growth.

Peter Wirth: Vice President, focuses on business development.

Global Presence and Collaboration

RTI-HS maintains a global footprint with nine offices across the US and Europe. This broad presence facilitates extensive collaboration and service to their international client base, achieved through integrated project teams that address diverse pharmaceutical and medical device research needs.

Commitment to Innovation and Industry Leadership

RTI-HS emphasizes innovation by experimenting with novel methodologies and embracing diversity. This commitment is integral to maintaining its industry-leading position. The company is driven by a mission to translate knowledge into practice, thereby enhancing human conditions through research characterized by corporate responsibility and sustainability.

Competitor Profiling for RTI Health Solutions

Overview

RTI Health Solutions operates within a competitive landscape filled with significant players in pharmaceutical research and health solutions. These competitors vary in specialization, market presence, and service offerings, presenting both challenges and potential partnership opportunities.

Primary Competitors

Global Pharma Tek (GPT)

Founded: 2011

Headquarters: New Jersey, USA

Global Presence: USA, Canada, India, UAE, Europe

Services: Offers comprehensive services including workforce solutions, pharmaceutical raw materials trading, drug development, clinical, and contract research.

Employee Strength: Over 350, aiming for 1000+ by 2025

Vision: Facilitating health improvement through innovative therapeutic solutions and bridging talent gaps.

Core Values: Encompass quality, value creation, excellence, integrity, and transparency.

IQVIA

Global Footprint: Operations in over 100 countries

Employee Base: Approximately 86,000

Specialization: Offers advanced analytics, technology solutions, and clinical research services to the life sciences sector.

Vision: Drives smarter global healthcare, enhancing outcomes through technological innovation and connected intelligence.

Medpace

Model: Full-service contract research organization (CRO)

Focus: Specializes in clinical pharmacology and laboratory services, renowned for therapeutic and regulatory expertise.

Reputation: Highly trusted by biotech companies for quality research services.

Optum

Parent Company: UnitedHealth Group

Headquarters: Eden Prairie, Minnesota

Employees: Over 310,000 worldwide

Services: Delivers health solutions and care specialization in data analytics, clinical experience, and professional partnerships.

Syneos Health

Services: Offers end-to-end biopharmaceutical solutions from clinical development to commercialization across Phase I to IV trials.

Market Presence: A leader in providing comprehensive outsourced solutions to the pharmaceutical and biotechnology sectors.

Strategic Insights

In this competitive landscape, enhancing technological and analytical capabilities is crucial for RTI Health Solutions. The strategic advancements of competitors such as IQVIA and Optum in connected intelligence and comprehensive healthcare solutions illustrate the necessity of advancing technology. Global Pharma Tek's focus on workforce innovation and strategic expansion highlights the importance of scalability and developing human capital. To remain competitive, RTI-HS must leverage existing strengths and explore strategic collaborations that complement its offerings. Aligning with innovative therapeutic solutions and healthcare intelligence trends may further sustain and enhance its market position.